Fig. 7

Risk of any infection in patients treated with clinical doses of CGRP-targeting medications. RR– relative risk, LL– lower limit, UL– upper limit)
Risk of any infection in patients treated with clinical doses of CGRP-targeting medications. RR– relative risk, LL– lower limit, UL– upper limit)